Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Medicare Part D Formulary Placement: Bundled Up, Or Out In The Cold?

Executive Summary

Pfizer appears to have taken an all-or-nothing approach to negotiating formulary positioning for its products in Medicare Part D prescription drug plans, according to an analysis by "The Pink Sheet" of plan formularies

You may also be interested in...



Part D 2007 Negotiations: Will Rebate Emphasis Change To Pricing Demands?

The major Part D plan sponsors may have favored receiving drug rebates over drug price discounts in negotiations with pharmaceutical manufacturers for the 2006 benefit year, based on a recently released 1analysis by the Kaiser Family Foundation

Part D 2007 Negotiations: Will Rebate Emphasis Change To Pricing Demands?

The major Part D plan sponsors may have favored receiving drug rebates over drug price discounts in negotiations with pharmaceutical manufacturers for the 2006 benefit year, based on a recently released 1analysis by the Kaiser Family Foundation

Pfizer Medicare Part D Negotiations Not Focusing On Dual-Eligible Plans

Pfizer is not prioritizing preferred tier positioning in negotiations with Medicare Part D drug plans expected to enroll large numbers of dual-eligibles due to the limited difference in brand tier copays for such beneficiaries

Related Content

UsernamePublicRestriction

Register

LL1135415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel